On Monday, Zomedica Corp (AMEX: ZOM) was -1.52% down from the session before settling in for the closing price of $0.15. A 52-week range for ZOM has been $0.12 – $0.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 78.21%. With a float of $963.11 million, this company’s outstanding shares have now reached $979.95 million.
Let’s determine the extent of company efficiency that accounts for 144 employees.
Zomedica Corp (ZOM) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Zomedica Corp stocks. The insider ownership of Zomedica Corp is 1.72%, while institutional ownership is 8.59%. The most recent insider transaction that took place on Jun 12 ’24, was worth 46,529. In this transaction Vice President of Sales of this company bought 299,993 shares at a rate of $0.16, taking the stock ownership to the 2,000,050 shares. Before that another transaction happened on Jun 11 ’24, when Company’s Vice President of Sales bought 500,000 for $0.15, making the entire transaction worth $75,100. This insider now owns 1,700,057 shares in total.
Zomedica Corp (ZOM) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2023, it has been observed that the corporation posted -0.01 earnings per share (EPS) during the time that was less than consensus figure (set at 0) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.0 per share during the current fiscal year.
Zomedica Corp (AMEX: ZOM) Trading Performance Indicators
You can see what Zomedica Corp (ZOM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 10.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.04
Technical Analysis of Zomedica Corp (ZOM)
Looking closely at Zomedica Corp (AMEX: ZOM), its last 5-days average volume was 2.85 million, which is a drop from its year-to-date volume of 5.58 million. As of the previous 9 days, the stock’s Stochastic %D was 25.21%. Additionally, its Average True Range was 0.01.
During the past 100 days, Zomedica Corp’s (ZOM) raw stochastic average was set at 38.16%, which indicates a significant increase from 5.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.03% in the past 14 days, which was lower than the 71.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1516, while its 200-day Moving Average is $0.1577. However, in the short run, Zomedica Corp’s stock first resistance to watch stands at $0.1505. Second resistance stands at $0.1523. The third major resistance level sits at $0.1535. If the price goes on to break the first support level at $0.1475, it is likely to go to the next support level at $0.1463. Should the price break the second support level, the third support level stands at $0.1445.
Zomedica Corp (AMEX: ZOM) Key Stats
There are 979,950K outstanding shares of the company, which has a market capitalization of 145.72 million. As of now, sales total 25,190 K while income totals -34,530 K. Its latest quarter income was 6,260 K while its last quarter net income were -9,160 K.
